Fingerprints have been used as a form of identification for centuries and were first used in a criminal investigation in 1892 to clear a man accused of murder. Blood tests became part of the medical landscape in 1901 with the identification of A, B and O blood types, and is now used for a huge range of tests from blood sugar for diabetes to HIV testing. The discovery of DNA and the double helix structure in 1953 is often thought of as the birth of modern molecular biology. The rise of FaceID and continued use of fingerprint identification puts a spotlight on what will be the next key step in learning from our body.
Our breath is often overlooked as a potential source of vital information, relegated to the task of breathalysers and measuring the fitness of elite athletes. However through the use of Nanoparticle Biomarker Tagging technology it will soon be possible to diagnose, with incredible accuracy and sensitivity, a range of serious diseases at the earliest possible stage purely from the contents of a minute’s worth of an individual’s breath.
Not only this but the breath test could in future be used to check our fitness, dietary requirements or overall health. Combined with AI technology, breath tests could reveal more about our bodies than ever before, the next step in understanding individual’s needs and ailments.
Wesley Baker – CEO of ANCON Medical – discusses the next step in diagnosis and identification:
“Each and every one of our breaths contains a plethora of information relating to everything from the presence of diseases to blood sugar levels. This could be one of the most significant steps in this field for years and revolutionise the industry of analysing the data our body provides. We have used the markers from our bodies for centuries to identify ourselves but the future promises to reveal more about the human body than ever before”
ANCON Medical are currently in the process of bringing this technology to the market to help vastly improve the survivability of lethal cancers with early detection and screening.